Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Chembio Diagnostics, Inc. (NASDAQ: CEMI) to Biosynex SA for $0.45 per share is fair to Chembio shareholders. Halper Sadeh encourages Chembio shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or
[email protected] or
[email protected] . The investigation concerns whether Chembio and its board of directors violated the...